Depression News

A single, 25 mg dose of synthetic psilocybin along with psychotherapy was safe and effective among individuals with bipolar II disorder depression, supporting further study of psychedelics for these patients, according to research.

An increase in symptoms of depression was linked to a small increase in weight among adults with overweight or obesity, according to a recent study in PLOS One.

Preliminary results from an ongoing FDA investigation found no evidence that weight-loss drugs cause suicidal ideations and aspirations, although the agency said it cannot rule out a risk entirely.

Women with clinically diagnosed perinatal depression have an increased risk for suicidal behavior, especially within the first year after diagnosis, according to findings published in JAMA Network Open.

Artificial intelligence-powered nutrition recommendations based on individuals’ molecular data were associated with significant improvements in anxiety, depression and more, according to studies by a company developing the technology.

Some of the most-viewed stories on Healio Psychiatry over the past year highlighted the FDA designating an at-home depression treatment as a breakthrough device as well as the transformative power of psychedelics.

Focusing on mental health is one of the most popular New Year’s resolutions U.S. adults are making for 2024, according to a press release from the American Psychiatric Association.

In the wake of record suicide numbers, primary care physicians are in a unique position to offer front-line mental health care, according to experts.

Current perinatal depression recommendations aim to help with early screening, diagnosis and treatment and to prevent maternal mortality.

Psilocybin significantly reduced depression symptoms in patients with cancer, results from a phase 2 study published in Cancer showed.